Vyvanse News
Most Popular Vyvanse Story
Shire hikes Adderall price as rumors fly
Amid new speculation that Pfizer might snag Shire in a buyout deal, the specialty pharma is following through on its strategy to switch patients to its newest ADHD med Vyvanse as blockbuster Adderall Read more...
Latest Headlines
- December 13, 2011
- November 18, 2011
- November 16, 2011
- July 13, 2011
- November 1, 2010
- March 4, 2010
- October 26, 2009
- May 6, 2009
- March 31, 2009
- January 8, 2009
- June 16, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
